tiprankstipranks
Trending News
More News >
Core Laboratories N.V. (CLB)
:CLB
US Market
Advertisement

Core Laboratories (CLB) Earnings Dates, Call Summary & Reports

Compare
211 Followers

Earnings Data

Report Date
Oct 22, 2025
After Close (Confirmed)
Period Ending
2025 (Q3)
Consensus EPS Forecast
0.21
Last Year’s EPS
0.25
Same Quarter Last Year
Based on 2 Analysts Ratings

Earnings Call Summary

Q2 2025
Earnings Call Date:Jul 23, 2025|
% Change Since: -14.83%|
Earnings Call Sentiment|Neutral
The earnings call reflected a mixed performance with positive developments in revenue growth and strategic initiatives, but challenges remain with flat year-over-year revenue, declining diagnostic services, and geopolitical uncertainties impacting international operations.
Company Guidance -
Q3 2025
During the Core Laboratories Q2 2025 earnings call, the company provided guidance indicating a projected revenue range of $127.5 million to $134.5 million for the third quarter, with operating income expected to be between $13.6 million and $16.2 million, yielding operating margins of 11%. Earnings per share (EPS) for the third quarter are anticipated to range from $0.18 to $0.22, based on an effective tax rate of 25%. The guidance reflects the company's expectations for steady international upstream activity and ongoing volatility in the U.S. onshore market due to geopolitical conflicts and fluctuating crude oil prices. Core Laboratories expects Reservoir Description's third-quarter revenue to remain flat, while Production Enhancement is projected to experience growth due to international and offshore demand. The company remains focused on maintaining a healthy balance sheet, as evidenced by a leverage ratio reduction to 1.27, and aims to use free cash flow to fund dividends, pursue growth opportunities, and conduct opportunistic share repurchases.
Revenue Growth
Second quarter 2025 revenue was up 5% compared to Q1, with improvements in operating income, operating margins, free cash flow, and earnings per share.
Reservoir Description Segment Performance
Revenue in the second quarter was up 7% compared to Q1. Operating margins increased from 10% in Q1 to 13% in Q2, reflecting continued demand for rock and fluid analysis and laboratory instrumentation sales.
Production Enhancement Segment Growth
Second quarter revenue was up 3% compared to Q1. Operating margins improved from 8% in Q1 to 9% in Q2, driven by demand for high-margin diagnostic services in the U.S. and improved international and domestic completion product sales.
Shareholder Returns and Debt Reduction
Core Lab repurchased over 237,000 shares, valued at $2.7 million, and reduced net debt by more than $9 million, achieving a leverage ratio of 1.27, the lowest in 8 years.
Innovative Technology and Strategic Initiatives
Continued introduction and deployment of new technologies like the HERO PerFRAC perforating system and geothermal energy project tracers, enhancing market position and client offerings.

Core Laboratories (CLB) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

CLB Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Oct 22, 2025
2025 (Q3)
0.21 / -
0.25
Jul 23, 2025
2025 (Q2)
0.19 / 0.19
0.22-13.64% (-0.03)
Apr 23, 2025
2025 (Q1)
0.14 / 0.14
0.19-26.32% (-0.05)
Jan 29, 2025
2024 (Q4)
0.22 / 0.22
0.1915.79% (+0.03)
Oct 23, 2024
2024 (Q3)
0.24 / 0.25
0.2213.64% (+0.03)
Jul 24, 2024
2024 (Q2)
0.20 / 0.22
0.214.76% (+0.01)
Apr 24, 2024
2024 (Q1)
0.16 / 0.19
0.190.00% (0.00)
Jan 31, 2024
2023 (Q4)
0.19 / 0.19
0.2-5.00% (-0.01)
Nov 01, 2023
2023 (Q3)
0.22 / 0.22
0.1822.22% (+0.04)
Jul 26, 2023
2023 (Q2)
0.20 / 0.21
0.1275.00% (+0.09)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

CLB Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Jul 23, 2025
$12.61$13.35+5.87%
Apr 23, 2025
$12.05$11.59-3.82%
Jan 29, 2025
$18.50$17.71-4.27%
Oct 23, 2024
$17.03$18.88+10.86%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Core Laboratories N.V. (CLB) report earnings?
Core Laboratories N.V. (CLB) is schdueled to report earning on Oct 22, 2025, After Close (Confirmed).
    What is Core Laboratories N.V. (CLB) earnings time?
    Core Laboratories N.V. (CLB) earnings time is at Oct 22, 2025, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is CLB EPS forecast?
          CLB EPS forecast for the fiscal quarter 2025 (Q3) is 0.21.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis